APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Molecular Docking and Virtual Screening Software

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Molecular Docking and Virtual Screening Software Market Analysis and Forecast 2026-2032

Report ID 174512860512 August 2026178 pages

Choose your research edition.

Industry ResearchMolecular Docking and Virtual Screening Software Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Molecular Docking and Virtual Screening Software Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Molecular Docking and Virtual Screening Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Molecular Docking and Virtual Screening Software Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Molecular Docking and Virtual Screening Software Market Analysis and Forecast 2026-2032178 pages · $4,950 USD

Market perspective

The global Molecular Docking and Virtual Screening Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Molecular Docking and Virtual Screening Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Molecular Docking and Virtual Screening Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Molecular Docking and Virtual Screening Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Molecular Docking and Virtual Screening Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Molecular Docking and Virtual Screening Software include OpenEye Cadence Molecular Sciences, Cambridge Crystallographic Data Centre, Cresset, BioSolveIT, Molsoft, Molecular Discovery, DP Technology, XtalPi and Schrödinger, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Molecular Docking and Virtual Screening Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Molecular Docking and Virtual Screening Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Molecular Docking and Virtual Screening Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Molecular Docking and Virtual Screening Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Molecular Docking and Virtual Screening Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Molecular Docking and Virtual Screening Software revenue, projected growth trends, production technology, application and end-user industry.

Molecular Docking and Virtual Screening Software Segment by Company

OpenEye Cadence Molecular Sciences

Cambridge Crystallographic Data Centre

Cresset

BioSolveIT

Molsoft

Molecular Discovery

DP Technology

XtalPi

Schrödinger

Dassault Systèmes

Chemical Computing Group

Molecular Docking and Virtual Screening Software Segment by Type

Structure-Based Docking Software

Ligand-Based Screening Software

Pharmacophore Screening Software

Shape and Electrostatic Similarity Software

AI-Assisted Docking Software

Molecular Docking and Virtual Screening Software Segment by Application

Hit Discovery

Lead Optimization

Drug Repurposing

Fragment-Based Drug Design

Target Validation and Mechanism Study

Teaching and Academic Research

Molecular Docking and Virtual Screening Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Docking and Virtual Screening Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Molecular Docking and Virtual Screening Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Docking and Virtual Screening Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Molecular Docking and Virtual Screening Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Molecular Docking and Virtual Screening Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Molecular Docking and Virtual Screening Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Molecular Docking and Virtual Screening Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Structure-Based Docking Software Major Player Table 3. Ligand-Based Screening Software Major Player Table 4. Pharmacophore Screening Software Major Player Table 5. Shape and Electrostatic Similarity Software Major Player Table 6. AI-Assisted Docking Software Major Player Table 7. Global Molecular Docking and Virtual Screening Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hit Discovery Major Player Table 9. Lead Optimization Major Player Table 10. Drug Repurposing Major Player Table 11. Fragment-Based Drug Design Major Player Table 12. Target Validation and Mechanism Study Major Player Table 13. Teaching and Academic Research Major Player Table 14. Molecular Docking and Virtual Screening Software Industry Trends Table 15. Molecular Docking and Virtual Screening Software Industry Drivers Table 16. Molecular Docking and Virtual Screening Software Industry Opportunities and Challenges Table 17. Molecular Docking and Virtual Screening Software Industry Restraints Table 18. Global Molecular Docking and Virtual Screening Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 19. Global Molecular Docking and Virtual Screening Software Market Size by Region (2021-2026) & (US$ Million) Table 20. Global Molecular Docking and Virtual Screening Software Market Share by Region (2021-2026) Table 21. Global Molecular Docking and Virtual Screening Software Market Size by Region (2027-2032) & (US$ Million) Table 22. Global Molecular Docking and Virtual Screening Software Market Share by Region (2027-2032) Table 23. Global Molecular Docking and Virtual Screening Software Revenue by Players (US$ Million) & (2021-2026) Table 24. Global Molecular Docking and Virtual Screening Software Revenue Market Share by Players (2021-2026) Table 25. Global Molecular Docking and Virtual Screening Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 26. Global Molecular Docking and Virtual Screening Software Key Players Headquarters & Area Served Table 27. Global Molecular Docking and Virtual Screening Software Players, Product Type & Application Table 28. Global Molecular Docking and Virtual Screening Software Players Establishment Date Table 29. Global Players Market Concentration Ratio (CR5 and HHI) Table 30. Global Molecular Docking and Virtual Screening Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 31. Global Molecular Docking and Virtual Screening Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Molecular Docking and Virtual Screening Software Revenue by Type (2021-2026) & (US$ Million) Table 33. Global Molecular Docking and Virtual Screening Software Revenue by Type (2027-2032) & (US$ Million) Table 34. Global Molecular Docking and Virtual Screening Software Revenue Market Share by Type (2021-2026) Table 35. Global Molecular Docking and Virtual Screening Software Revenue Market Share by Type (2027-2032) Table 36. Global Molecular Docking and Virtual Screening Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Molecular Docking and Virtual Screening Software Revenue by Application (2021-2026) & (US$ Million) Table 38. Global Molecular Docking and Virtual Screening Software Revenue by Application (2027-2032) & (US$ Million) Table 39. Global Molecular Docking and Virtual Screening Software Revenue Market Share by Application (2021-2026) Table 40. Global Molecular Docking and Virtual Screening Software Revenue Market Share by Application (2027-2032) Table 41. OpenEye Cadence Molecular Sciences Company Information Table 42. OpenEye Cadence Molecular Sciences Business Overview Table 43. OpenEye Cadence Molecular Sciences Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. OpenEye Cadence Molecular Sciences Molecular Docking and Virtual Screening Software Product Portfolio Table 45. OpenEye Cadence Molecular Sciences Recent Development Table 46. Cambridge Crystallographic Data Centre Company Information Table 47. Cambridge Crystallographic Data Centre Business Overview Table 48. Cambridge Crystallographic Data Centre Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Cambridge Crystallographic Data Centre Molecular Docking and Virtual Screening Software Product Portfolio Table 50. Cambridge Crystallographic Data Centre Recent Development Table 51. Cresset Company Information Table 52. Cresset Business Overview Table 53. Cresset Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Cresset Molecular Docking and Virtual Screening Software Product Portfolio Table 55. Cresset Recent Development Table 56. BioSolveIT Company Information Table 57. BioSolveIT Business Overview Table 58. BioSolveIT Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. BioSolveIT Molecular Docking and Virtual Screening Software Product Portfolio Table 60. BioSolveIT Recent Development Table 61. Molsoft Company Information Table 62. Molsoft Business Overview Table 63. Molsoft Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Molsoft Molecular Docking and Virtual Screening Software Product Portfolio Table 65. Molsoft Recent Development Table 66. Molecular Discovery Company Information Table 67. Molecular Discovery Business Overview Table 68. Molecular Discovery Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Molecular Discovery Molecular Docking and Virtual Screening Software Product Portfolio Table 70. Molecular Discovery Recent Development Table 71. DP Technology Company Information Table 72. DP Technology Business Overview Table 73. DP Technology Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. DP Technology Molecular Docking and Virtual Screening Software Product Portfolio Table 75. DP Technology Recent Development Table 76. XtalPi Company Information Table 77. XtalPi Business Overview Table 78. XtalPi Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. XtalPi Molecular Docking and Virtual Screening Software Product Portfolio Table 80. XtalPi Recent Development Table 81. Schrödinger Company Information Table 82. Schrödinger Business Overview Table 83. Schrödinger Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Schrödinger Molecular Docking and Virtual Screening Software Product Portfolio Table 85. Schrödinger Recent Development Table 86. Dassault Systèmes Company Information Table 87. Dassault Systèmes Business Overview Table 88. Dassault Systèmes Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Dassault Systèmes Molecular Docking and Virtual Screening Software Product Portfolio Table 90. Dassault Systèmes Recent Development Table 91. Chemical Computing Group Company Information Table 92. Chemical Computing Group Business Overview Table 93. Chemical Computing Group Molecular Docking and Virtual Screening Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Chemical Computing Group Molecular Docking and Virtual Screening Software Product Portfolio Table 95. Chemical Computing Group Recent Development Table 96. North America Molecular Docking and Virtual Screening Software Revenue by Type (2021-2026) & (US$ Million) Table 97. North America Molecular Docking and Virtual Screening Software Revenue by Type (2027-2032) & (US$ Million) Table 98. North America Molecular Docking and Virtual Screening Software Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Molecular Docking and Virtual Screening Software Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Molecular Docking and Virtual Screening Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Molecular Docking and Virtual Screening Software Revenue by Country (2021-2026) & (US$ Million) Table 102. North America Molecular Docking and Virtual Screening Software Revenue by Country (US$ Million) & (2027-2032) Table 103. Europe Molecular Docking and Virtual Screening Software Revenue by Type (2021-2026) & (US$ Million) Table 104. Europe Molecular Docking and Virtual Screening Software Revenue by Type (2027-2032) & (US$ Million) Table 105. Europe Molecular Docking and Virtual Screening Software Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe Molecular Docking and Virtual Screening Software Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe Molecular Docking and Virtual Screening Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Molecular Docking and Virtual Screening Software Revenue by Country (2021-2026) & (US$ Million) Table 109. Europe Molecular Docking and Virtual Screening Software Revenue by Country (US$ Million) & (2027-2032) Table 110. China Molecular Docking and Virtual Screening Software Revenue by Type (2021-2026) & (US$ Million) Table 111. China Molecular Docking and Virtual Screening Software Revenue by Type (2027-2032) & (US$ Million) Table 112. China Molecular Docking and Virtual Screening Software Revenue by Application (2021-2026) & (US$ Million) Table 113. China Molecular Docking and Virtual Screening Software Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia Molecular Docking and Virtual Screening Software Revenue by Type (2021-2026) & (US$ Million) Table 115. Asia Molecular Docking and Virtual Screening Software Revenue by Type (2027-2032) & (US$ Million) Table 116. Asia Molecular Docking and Virtual Screening Software Revenue by Application (2021-2026) & (US$ Million) Table 117. Asia Molecular Docking and Virtual Screening Software Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Molecular Docking and Virtual Screening Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Asia Molecular Docking and Virtual Screening Software Revenue by Region (US$ Million) & (2021-2026) Table 120. Asia Molecular Docking and Virtual Screening Software Revenue by Region (US$ Million) & (2027-2032) Table 121. SAMEA Molecular Docking and Virtual Screening Software Revenue by Type (2021-2026) & (US$ Million) Table 122. SAMEA Molecular Docking and Virtual Screening Software Revenue by Type (2027-2032) & (US$ Million) Table 123. SAMEA Molecular Docking and Virtual Screening Software Revenue by Application (2021-2026) & (US$ Million) Table 124. SAMEA Molecular Docking and Virtual Screening Software Revenue by Application (2027-2032) & (US$ Million) Table 125. SAMEA Molecular Docking and Virtual Screening Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. SAMEA Molecular Docking and Virtual Screening Software Revenue by Country (2021-2026) & (US$ Million) Table 127. SAMEA Molecular Docking and Virtual Screening Software Revenue by Country (US$ Million) & (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Molecular Docking and Virtual Screening Software Image Figure 2. Global Molecular Docking and Virtual Screening Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Molecular Docking and Virtual Screening Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. Structure-Based Docking Software Image Figure 5. Ligand-Based Screening Software Image Figure 6. Pharmacophore Screening Software Image Figure 7. Shape and Electrostatic Similarity Software Image Figure 8. AI-Assisted Docking Software Image Figure 9. Global Molecular Docking and Virtual Screening Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Molecular Docking and Virtual Screening Software Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hit Discovery Image Figure 12. Lead Optimization Image Figure 13. Drug Repurposing Image Figure 14. Fragment-Based Drug Design Image Figure 15. Target Validation and Mechanism Study Image Figure 16. Teaching and Academic Research Image Figure 17. Global Molecular Docking and Virtual Screening Software Market Size (US$ Million) & (2021-2032) Figure 18. Global Molecular Docking and Virtual Screening Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Molecular Docking and Virtual Screening Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 20. Global Molecular Docking and Virtual Screening Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Molecular Docking and Virtual Screening Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Molecular Docking and Virtual Screening Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Molecular Docking and Virtual Screening Software Revenue Market Share by Type (2021-2032) Figure 25. Global Molecular Docking and Virtual Screening Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Molecular Docking and Virtual Screening Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 27. Global Molecular Docking and Virtual Screening Software Revenue Market Share by Application (2021-2032) Figure 28. North America Molecular Docking and Virtual Screening Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. North America Molecular Docking and Virtual Screening Software Revenue Share by Type (2021-2032) Figure 30. North America Molecular Docking and Virtual Screening Software Revenue Share by Application (2021-2032) Figure 31. North America Molecular Docking and Virtual Screening Software Revenue Share by Country (2021-2032) Figure 32. United States Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Canada Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Mexico Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Europe Molecular Docking and Virtual Screening Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 36. Europe Molecular Docking and Virtual Screening Software Revenue Share by Type (2021-2032) Figure 37. Europe Molecular Docking and Virtual Screening Software Revenue Share by Application (2021-2032) Figure 38. Europe Molecular Docking and Virtual Screening Software Revenue Share by Country (2021-2032) Figure 39. Germany Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. France Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. U.K. Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Italy Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Spain Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Russia Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Netherlands Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Nordic Countries Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. China Molecular Docking and Virtual Screening Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. China Molecular Docking and Virtual Screening Software Revenue Share by Type (2021-2032) Figure 49. China Molecular Docking and Virtual Screening Software Revenue Share by Application (2021-2032) Figure 50. Asia Molecular Docking and Virtual Screening Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 51. Asia Molecular Docking and Virtual Screening Software Revenue Share by Type (2021-2032) Figure 52. Asia Molecular Docking and Virtual Screening Software Revenue Share by Application (2021-2032) Figure 53. Asia Molecular Docking and Virtual Screening Software Revenue Share by Region (2021-2032) Figure 54. Japan Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. South Korea Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. India Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Australia Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Taiwan Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Southeast Asia Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. SAMEA Molecular Docking and Virtual Screening Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 61. SAMEA Molecular Docking and Virtual Screening Software Revenue Share by Type (2021-2032) Figure 62. SAMEA Molecular Docking and Virtual Screening Software Revenue Share by Application (2021-2032) Figure 63. SAMEA Molecular Docking and Virtual Screening Software Revenue Share by Country (2021-2032) Figure 64. Brazil Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Argentina Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Chile Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Colombia Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Peru Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Saudi Arabia Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Israel Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. UAE Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Turkey Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Iran Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Egypt Molecular Docking and Virtual Screening Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Structure-Based Docking Software
  • Ligand-Based Screening Software
  • Pharmacophore Screening Software
  • Shape and Electrostatic Similarity Software
  • AI-Assisted Docking Software
Applications
  • Hit Discovery
  • Lead Optimization
  • Drug Repurposing
  • Fragment-Based Drug Design
  • Target Validation and Mechanism Study
  • Teaching and Academic Research
Companies covered
  • OpenEye Cadence Molecular Sciences
  • Cambridge Crystallographic Data Centre
  • Cresset
  • BioSolveIT
  • Molsoft
  • Molecular Discovery
  • DP Technology
  • XtalPi
  • Schrödinger
  • Dassault Systèmes
  • Chemical Computing Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Molecular Docking and Virtual Screening Software Market by Type
  3. 1.2.1 Global Molecular Docking and Virtual Screening Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Structure-Based Docking Software
  5. 1.2.3 Ligand-Based Screening Software
  6. 1.2.4 Pharmacophore Screening Software
  7. 1.2.5 Shape and Electrostatic Similarity Software
  8. 1.2.6 AI-Assisted Docking Software
  9. 1.3 Molecular Docking and Virtual Screening Software Market by Application
  10. 1.3.1 Global Molecular Docking and Virtual Screening Software Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hit Discovery
  12. 1.3.3 Lead Optimization
  13. 1.3.4 Drug Repurposing
  14. 1.3.5 Fragment-Based Drug Design
  15. 1.3.6 Target Validation and Mechanism Study
  16. 1.3.7 Teaching and Academic Research
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Molecular Docking and Virtual Screening Software Market Dynamics
  1. 2.1 Molecular Docking and Virtual Screening Software Industry Trends
  2. 2.2 Molecular Docking and Virtual Screening Software Industry Drivers
  3. 2.3 Molecular Docking and Virtual Screening Software Industry Opportunities and Challenges
  4. 2.4 Molecular Docking and Virtual Screening Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Molecular Docking and Virtual Screening Software Market Perspective (2021-2032)
  2. 3.2 Global Molecular Docking and Virtual Screening Software Growth Trends by Region
  3. 3.2.1 Global Molecular Docking and Virtual Screening Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Molecular Docking and Virtual Screening Software Market Size by Region (2021-2026)
  5. 3.2.3 Global Molecular Docking and Virtual Screening Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Molecular Docking and Virtual Screening Software Revenue by Players
  2. 4.1.1 Global Molecular Docking and Virtual Screening Software Revenue by Players (2021-2026)
  3. 4.1.2 Global Molecular Docking and Virtual Screening Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Molecular Docking and Virtual Screening Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Molecular Docking and Virtual Screening Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Molecular Docking and Virtual Screening Software Key Players Headquarters & Area Served
  7. 4.4 Global Molecular Docking and Virtual Screening Software Players, Product Type & Application
  8. 4.5 Global Molecular Docking and Virtual Screening Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Molecular Docking and Virtual Screening Software Market CR5 and HHI
  11. 4.6.3 2025 Molecular Docking and Virtual Screening Software Tier 1, Tier 2, and Tier 3
5 Molecular Docking and Virtual Screening Software Market Size by Type
  1. 5.1 Global Molecular Docking and Virtual Screening Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Molecular Docking and Virtual Screening Software Revenue by Type (2021-2032)
  3. 5.3 Global Molecular Docking and Virtual Screening Software Revenue Market Share by Type (2021-2032)
6 Molecular Docking and Virtual Screening Software Market Size by Application
  1. 6.1 Global Molecular Docking and Virtual Screening Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Molecular Docking and Virtual Screening Software Revenue by Application (2021-2032)
  3. 6.3 Global Molecular Docking and Virtual Screening Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 OpenEye Cadence Molecular Sciences
  2. 7.1.1 OpenEye Cadence Molecular Sciences Company Information
  3. 7.1.2 OpenEye Cadence Molecular Sciences Business Overview
  4. 7.1.3 OpenEye Cadence Molecular Sciences Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 OpenEye Cadence Molecular Sciences Molecular Docking and Virtual Screening Software Product Portfolio
  6. 7.1.5 OpenEye Cadence Molecular Sciences Recent Developments
  7. 7.2 Cambridge Crystallographic Data Centre
  8. 7.2.1 Cambridge Crystallographic Data Centre Company Information
  9. 7.2.2 Cambridge Crystallographic Data Centre Business Overview
  10. 7.2.3 Cambridge Crystallographic Data Centre Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Cambridge Crystallographic Data Centre Molecular Docking and Virtual Screening Software Product Portfolio
  12. 7.2.5 Cambridge Crystallographic Data Centre Recent Developments
  13. 7.3 Cresset
  14. 7.3.1 Cresset Company Information
  15. 7.3.2 Cresset Business Overview
  16. 7.3.3 Cresset Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Cresset Molecular Docking and Virtual Screening Software Product Portfolio
  18. 7.3.5 Cresset Recent Developments
  19. 7.4 BioSolveIT
  20. 7.4.1 BioSolveIT Company Information
  21. 7.4.2 BioSolveIT Business Overview
  22. 7.4.3 BioSolveIT Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 BioSolveIT Molecular Docking and Virtual Screening Software Product Portfolio
  24. 7.4.5 BioSolveIT Recent Developments
  25. 7.5 Molsoft
  26. 7.5.1 Molsoft Company Information
  27. 7.5.2 Molsoft Business Overview
  28. 7.5.3 Molsoft Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Molsoft Molecular Docking and Virtual Screening Software Product Portfolio
  30. 7.5.5 Molsoft Recent Developments
  31. 7.6 Molecular Discovery
  32. 7.6.1 Molecular Discovery Company Information
  33. 7.6.2 Molecular Discovery Business Overview
  34. 7.6.3 Molecular Discovery Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Molecular Discovery Molecular Docking and Virtual Screening Software Product Portfolio
  36. 7.6.5 Molecular Discovery Recent Developments
  37. 7.7 DP Technology
  38. 7.7.1 DP Technology Company Information
  39. 7.7.2 DP Technology Business Overview
  40. 7.7.3 DP Technology Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 DP Technology Molecular Docking and Virtual Screening Software Product Portfolio
  42. 7.7.5 DP Technology Recent Developments
  43. 7.8 XtalPi
  44. 7.8.1 XtalPi Company Information
  45. 7.8.2 XtalPi Business Overview
  46. 7.8.3 XtalPi Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 XtalPi Molecular Docking and Virtual Screening Software Product Portfolio
  48. 7.8.5 XtalPi Recent Developments
  49. 7.9 Schrödinger
  50. 7.9.1 Schrödinger Company Information
  51. 7.9.2 Schrödinger Business Overview
  52. 7.9.3 Schrödinger Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Schrödinger Molecular Docking and Virtual Screening Software Product Portfolio
  54. 7.9.5 Schrödinger Recent Developments
  55. 7.10 Dassault Systèmes
  56. 7.10.1 Dassault Systèmes Company Information
  57. 7.10.2 Dassault Systèmes Business Overview
  58. 7.10.3 Dassault Systèmes Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Dassault Systèmes Molecular Docking and Virtual Screening Software Product Portfolio
  60. 7.10.5 Dassault Systèmes Recent Developments
  61. 7.11 Chemical Computing Group
  62. 7.11.1 Chemical Computing Group Company Information
  63. 7.11.2 Chemical Computing Group Business Overview
  64. 7.11.3 Chemical Computing Group Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Chemical Computing Group Molecular Docking and Virtual Screening Software Product Portfolio
  66. 7.11.5 Chemical Computing Group Recent Developments
8 North America
  1. 8.1 North America Molecular Docking and Virtual Screening Software Revenue (2021-2032)
  2. 8.2 North America Molecular Docking and Virtual Screening Software Revenue by Type (2021-2032)
  3. 8.2.1 North America Molecular Docking and Virtual Screening Software Revenue by Type (2021-2026)
  4. 8.2.2 North America Molecular Docking and Virtual Screening Software Revenue by Type (2027-2032)
  5. 8.3 North America Molecular Docking and Virtual Screening Software Revenue Share by Type (2021-2032)
  6. 8.4 North America Molecular Docking and Virtual Screening Software Revenue by Application (2021-2032)
  7. 8.4.1 North America Molecular Docking and Virtual Screening Software Revenue by Application (2021-2026)
  8. 8.4.2 North America Molecular Docking and Virtual Screening Software Revenue by Application (2027-2032)
  9. 8.5 North America Molecular Docking and Virtual Screening Software Revenue Share by Application (2021-2032)
  10. 8.6 North America Molecular Docking and Virtual Screening Software Revenue by Country
  11. 8.6.1 North America Molecular Docking and Virtual Screening Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Molecular Docking and Virtual Screening Software Revenue by Country (2021-2026)
  13. 8.6.3 North America Molecular Docking and Virtual Screening Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Molecular Docking and Virtual Screening Software Revenue (2021-2032)
  2. 9.2 Europe Molecular Docking and Virtual Screening Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe Molecular Docking and Virtual Screening Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe Molecular Docking and Virtual Screening Software Revenue by Type (2027-2032)
  5. 9.3 Europe Molecular Docking and Virtual Screening Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe Molecular Docking and Virtual Screening Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe Molecular Docking and Virtual Screening Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe Molecular Docking and Virtual Screening Software Revenue by Application (2027-2032)
  9. 9.5 Europe Molecular Docking and Virtual Screening Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe Molecular Docking and Virtual Screening Software Revenue by Country
  11. 9.6.1 Europe Molecular Docking and Virtual Screening Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Molecular Docking and Virtual Screening Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe Molecular Docking and Virtual Screening Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Molecular Docking and Virtual Screening Software Revenue (2021-2032)
  2. 10.2 China Molecular Docking and Virtual Screening Software Revenue by Type (2021-2032)
  3. 10.2.1 China Molecular Docking and Virtual Screening Software Revenue by Type (2021-2026)
  4. 10.2.2 China Molecular Docking and Virtual Screening Software Revenue by Type (2027-2032)
  5. 10.3 China Molecular Docking and Virtual Screening Software Revenue Share by Type (2021-2032)
  6. 10.4 China Molecular Docking and Virtual Screening Software Revenue by Application (2021-2032)
  7. 10.4.1 China Molecular Docking and Virtual Screening Software Revenue by Application (2021-2026)
  8. 10.4.2 China Molecular Docking and Virtual Screening Software Revenue by Application (2027-2032)
  9. 10.5 China Molecular Docking and Virtual Screening Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Molecular Docking and Virtual Screening Software Revenue (2021-2032)
  2. 11.2 Asia Molecular Docking and Virtual Screening Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia Molecular Docking and Virtual Screening Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia Molecular Docking and Virtual Screening Software Revenue by Type (2027-2032)
  5. 11.3 Asia Molecular Docking and Virtual Screening Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia Molecular Docking and Virtual Screening Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia Molecular Docking and Virtual Screening Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia Molecular Docking and Virtual Screening Software Revenue by Application (2027-2032)
  9. 11.5 Asia Molecular Docking and Virtual Screening Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia Molecular Docking and Virtual Screening Software Revenue by Country
  11. 11.6.1 Asia Molecular Docking and Virtual Screening Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Molecular Docking and Virtual Screening Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia Molecular Docking and Virtual Screening Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Molecular Docking and Virtual Screening Software Revenue (2021-2032)
  2. 12.2 SAMEA Molecular Docking and Virtual Screening Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Molecular Docking and Virtual Screening Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Molecular Docking and Virtual Screening Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA Molecular Docking and Virtual Screening Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Molecular Docking and Virtual Screening Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Molecular Docking and Virtual Screening Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Molecular Docking and Virtual Screening Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA Molecular Docking and Virtual Screening Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Molecular Docking and Virtual Screening Software Revenue by Country
  11. 12.6.1 SAMEA Molecular Docking and Virtual Screening Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Molecular Docking and Virtual Screening Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Molecular Docking and Virtual Screening Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst